نتایج جستجو برای: heart failure arginine vasopressin tolvaptan drug therapy
تعداد نتایج: 1725442 فیلتر نتایج به سال:
Autosomal dominant polycystic kidney disease (ADPKD) is a cause of end-stage (ESKD). The vasopressin V2-receptor antagonist tolvaptan has been shown within randomized clinical trials to slow down decline function in patients with ADPKD at risk rapid progression. We performed retrospective review Northeast England cohort adult who had established on therapy determine its efficacy real-world clin...
Treatment of chronic heart failure (HF) is based on interference with the renin-angiotensin-aldosterone system and the adrenergic nervous system. Diuretics are used in volume-expanded patients. Insights from clinical trials and registries establish the need to consider correcting both cardiac loading conditions and nonload-related biological factors if HF therapy is to be optimized. Arginine va...
Objective Tolvaptan was first approved for use for cirrhosis in Japan in September 2013. The aim of the study was to examine the effect of tolvaptan, a vasopressin V2 receptor antagonist, on the prognosis of cirrhosis. Methods The effect of tolvaptan was evaluated in 26 patients with cirrhosis treated at our hospital from September 2013 to April 2015. Results The primary disease was hepatitis C...
An indispensable role for the brain renin-angiotensin system (RAS) has been documented in most experimental animal models of hypertension. To identify the specific efferent pathway activated by the brain RAS that mediates hypertension, we examined the hypothesis that elevated arginine vasopressin (AVP) release is necessary for hypertension in a double-transgenic model of brain-specific RAS hype...
objective: congestive heart failure (chf) has become one of the most important health care problems in western countries. this article focuses on the outpatient diagnosis and management of heart failure. we want to compare the outcome of patients who were treated with high dose diuretics in the emergency department (ed) without admission with patients who were admitted to hospital for standard ...
An exaggerated increase in circulatory blood volume is linked to congestive heart failure. Despite this increase, reduction of the "effective circulatory blood volume" in congestive heart failure is associated with decreased cardiac output, and can weaken the sensitivity of baroreceptors. Thereafter, tonic inhibition of the baroreceptor-mediated afferent pathway of vagal nerves is removed, prov...
The publication of the guideline by the European Renal Best Practice (ERBP) group has helped stimulate a debate on this important cause of morbidity and mortality (1, 2), and this joins an ever-growing body of international and national guidelinesonhyponatraemia.This includes the international expert panel recommendations by Verbalis et al. (3), and various national recommendations from Spain (...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید